Marie Therese Labro

Summary

Country: France

Publications

  1. ncbi Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?
    M T Labro
    INSERM U 479, Faculte Xavier Bichat, 75018 Paris, France
    Clin Microbiol Rev 13:615-50. 2000
  2. ncbi Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR)
    M T Labro
    INSERM U479, CHU X Bichat, Paris, France
    J Chemother 17:385-92. 2005
  3. ncbi Biotechnology--Fourth Croatian International Scientific Conference. Biotechnology and immunomodulatory drugs
    Marie-Therese Labro
    Faculte Xavier Bichat, Service d'Hematologie et d'Immunologie Biologiques, CHU Xavier Bichat, INSERM U479, 16 rue Henri Huchard, 75018 Paris, France
    IDrugs 8:290-3. 2005
  4. ncbi Anti-inflammatory activity of ansamycins
    Marie Therese Labro
    INSERM, U479, CHU Xavier Bichat, 16 rue Henri Huchard, 75018, Paris, France
    Expert Rev Anti Infect Ther 3:91-103. 2005
  5. ncbi Cellular and molecular effects of macrolides on leukocyte function
    Marie Therese Labro
    INSERM U479, CHU X Bichat, 16 rue Henri Huchard, Paris, France
    Curr Pharm Des 10:3067-80. 2004
  6. ncbi Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro
    Marie Therese Labro
    INSERM U479, CHU Xavier Bichat, 75018, Paris, France
    Antimicrob Agents Chemother 48:1096-104. 2004
  7. ncbi Macrolide antibiotics: current and future uses
    Marie Therese Labro
    INSERM, Paris, France
    Expert Opin Pharmacother 5:541-50. 2004
  8. ncbi Antibiotics as anti-inflammatory agents
    Marie Therese Labro
    INSERM U 479, CHU X Bichat, Paris, France
    Curr Opin Investig Drugs 3:61-8. 2002
  9. ncbi Immunomodulation by macrolide antibiotics
    M T Labro
    INSERM U479, CHU Xavier Bichat, Paris, France
    J Chemother 13:3-8. 2001
  10. ncbi Modulation of tissue factor expression by rapamycin and FK-506 in lipopolysaccharide-stimulated human mononuclear cells and serum-stimulated aortic smooth muscle cells
    Veronique Ollivier
    INSERM U479, Faculte Xavier Bichat, BP416 75870 Paris, Cedex 18 France
    Thromb Haemost 94:46-52. 2005

Collaborators

Detail Information

Publications11

  1. ncbi Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?
    M T Labro
    INSERM U 479, Faculte Xavier Bichat, 75018 Paris, France
    Clin Microbiol Rev 13:615-50. 2000
    ....
  2. ncbi Accumulation of azithromycin and roxithromycin in tracheal epithelial fetal cell lines expressing wild type or mutated cystic fibrosis transmembrane conductance regulator protein (CFTR)
    M T Labro
    INSERM U479, CHU X Bichat, Paris, France
    J Chemother 17:385-92. 2005
    ..These data suggest that the macrolide carriers (for entry and efflux) are not strictly specific for phagocytes and that the CFTR protein plays a role in macrolide uptake...
  3. ncbi Biotechnology--Fourth Croatian International Scientific Conference. Biotechnology and immunomodulatory drugs
    Marie-Therese Labro
    Faculte Xavier Bichat, Service d'Hematologie et d'Immunologie Biologiques, CHU Xavier Bichat, INSERM U479, 16 rue Henri Huchard, 75018 Paris, France
    IDrugs 8:290-3. 2005
  4. ncbi Anti-inflammatory activity of ansamycins
    Marie Therese Labro
    INSERM, U479, CHU Xavier Bichat, 16 rue Henri Huchard, 75018, Paris, France
    Expert Rev Anti Infect Ther 3:91-103. 2005
    ..However, biosynthetic manipulation remains an attractive route for the generation of pharmacologically useful analogs...
  5. ncbi Cellular and molecular effects of macrolides on leukocyte function
    Marie Therese Labro
    INSERM U479, CHU X Bichat, 16 rue Henri Huchard, Paris, France
    Curr Pharm Des 10:3067-80. 2004
    ..Novel analytical methods will certainly lead to new macrolide-based therapeutic strategies in cancer and inflammation...
  6. ncbi Interaction of the new ketolide ABT-773 (cethromycin) with human polymorphonuclear neutrophils and the phagocytic cell line PLB-985 in vitro
    Marie Therese Labro
    INSERM U479, CHU Xavier Bichat, 75018, Paris, France
    Antimicrob Agents Chemother 48:1096-104. 2004
    ..These data extend our previous results on the existence of an active transport system common to all macrolides and ketolides, at least in PMNs...
  7. ncbi Macrolide antibiotics: current and future uses
    Marie Therese Labro
    INSERM, Paris, France
    Expert Opin Pharmacother 5:541-50. 2004
    ..However, no clearcut results have yet been obtained...
  8. ncbi Antibiotics as anti-inflammatory agents
    Marie Therese Labro
    INSERM U 479, CHU X Bichat, Paris, France
    Curr Opin Investig Drugs 3:61-8. 2002
    ..Structure-activity relationships are the key to developing new anti-inflammatory agents derived from antibacterial drugs...
  9. ncbi Immunomodulation by macrolide antibiotics
    M T Labro
    INSERM U479, CHU Xavier Bichat, Paris, France
    J Chemother 13:3-8. 2001
    ....
  10. ncbi Modulation of tissue factor expression by rapamycin and FK-506 in lipopolysaccharide-stimulated human mononuclear cells and serum-stimulated aortic smooth muscle cells
    Veronique Ollivier
    INSERM U479, Faculte Xavier Bichat, BP416 75870 Paris, Cedex 18 France
    Thromb Haemost 94:46-52. 2005
    ..In addition to its recently established efficacy in the prevention of stent restenosis, the inhibitory effect of rapamycin on the TF pathway might have interesting therapeutic implications...
  11. ncbi [The strategy against influenza]
    Marie Therese Labro
    Centre d expertise collective Inserm, SC14, Faculte de Medecine Xavier Bichat, 75870 Paris Cedex 18
    Rev Prat 60:81-92. 2010
    ..Such a mobilization of government and scientific community has been beneficial at the onset of pandemic A(H1N1). WHO continues to monitor A(H1N1) pandemics worldwide, based on results of clinical studies and specific research...